These results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the strategy of focusing on ACKR3 as a unique approach to modulate the opioid method, which could open up new therapeutic avenues for opioid-associated Conditions. At that time, Microsoft https://friedrichp476dnh5.bmswiki.com/user